Author:
Kislitsyna N. M.,Kolesnik S. V.,Novikov S. V.,Kolesnik A. I.,Veselkova M. P.
Abstract
The contrast agents in vitreoretinal surgery are necessary to ensure the visualization of translucent and ultra-thin membranes and vitreoretinal interface (VRI) structures, but the ideal staining agent has not been found yet.Purpose. To investigate and compare staining properties of two vital dyes for vitreous body (VB) and vitreoretinal interface visualization: “Kenalog-40” and “Vitreocontrast”.Patients and methods. The study was performed on 20 cadaveric eyes. After eyeball dissection with the original technology, we carried out posterior vitreous cortex separation and comparative staining of retinal fragments on the side of VB and corresponding section of the VB by “Kenalog-40” and “Vitreokontrast”. Vitreo-retinal interface samples underwent morphological analysis.Results. In contrast to «Kenalog-40», «Vitreocontrast» enables the visualization of thin layer of VB on retina surface after splitting of cortical layers during posterior vitreous detachment induction. Upon that, the adherent particles of the “Vitreocontrast” suspension remained on the corresponding splitted fragment of the VB. After staining with “Kenalog-40”, the VB surface remained smooth, shiny, with no visible changes. The results of histological examination of the obtained retinal and VB samples confirmed the presence of VB layer on the retina surface at the site of vitreoshisis formation during the induction of posterior vitreous detachment.Conclutions. Received data confirm the possibility of vitreoshisis formation during posterior vitreous body detachment, and demonstrate the advantages of the staining properties of the “Vitreokontrast” suspension for visualization of fine structures of vitreoretinal interface.
Publisher
PE Polunina Elizareta Gennadievna
Reference18 articles.
1. Graham R.O., Peyman G.A. Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis. Arch Ophthalmol. 1974;92(2):149–154. DOI: 10.1001/archopht.1974.01010010155016
2. Machemer R., Sugita G., Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc. 1979;77:171–80.
3. Machemer R. Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor lecture. Invest Ophthalmol Vis Sci. 1988;29(12):1771–83.
4. Шкворченко Д.О., Кислицына Н.М., Колесник С.В., Колесник А.И., Какунина С.А., Норман К.С., Крупина Е.А. Контрастирующие вещества для хромовитрэктомии. Офтальмохирургия. 2016;2(2):70–77. [Shrvorchenko D.O., Kolesnik S.V., Kislitsina N.M., Kakunina S.A., Norman K.S., Kolesnik A.I., Krupina E.A. Vital dyes for chromovitrectomy. Ophtalmosurgery=Fyodorov Journal of Ophthalmic Surgery. 2016;(2):70–77. (In Russ.)] DOI: 10.25276/0235-4160-2016-2-70-77
5. Peyman G.A., Cheema R., Conway M.D. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina. 2000;20(5):554–5.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献